Antonio Santoro, Elena Mancini  Kidney International 

Slides:



Advertisements
Similar presentations
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.
Advertisements

Volume 86, Issue 2, Pages (August 2014)
Beta blockers in the management of chronic kidney disease
Volume 88, Issue 5, Pages (November 2015)
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Use of hemodialysis and hemoperfusion in poisoned patients
Anemia management in chronic kidney disease
Volume 83, Issue 3, Pages (March 2013)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
C-reactive protein and dialysis access
Volume 68, Issue 5, Pages (November 2005)
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
The risk of hospitalization and modality failure with home dialysis
Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)
Volume 86, Issue 2, Pages (August 2014)
C-reactive protein and dialysis access
Volume 75, Issue 11, Pages (June 2009)
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
G. Murcutt, J. Edwards, J. Boakye, A. Davenport  Kidney International 
Comorbidity and confounding in end-stage renal disease
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Severe exfoliative skin rash with icodextrin
Body weight is a fluctuating parameter in hemodialysis patients
Volume 77, Issue 2, Pages (January 2010)
Nephrology Crosswords: Hemodialysis
Volume 87, Issue 2, Pages (February 2015)
Edmund G. Lowrie  Kidney International 
The calcium–phosphorus in guidelines for CKD-MBD
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Volume 75, Issue 1, Pages (January 2009)
Prescribing and monitoring hemodialysis dose
Blood pressure targets in hemodialysis patients
Volume 73, Issue 12, Pages (June 2008)
Volume 75, Issue 11, Pages (June 2009)
Volume 76, Issue 6, Pages (September 2009)
Effects of hemodialysis on cardiac function
Clifford J. Holmes, Dirk Faict  Kidney International 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Cardiovascular disease in pediatric chronic dialysis patients
Hepatitis C treatment in patients with kidney disease
Extracorporeal removal of toxins
Nephrology Crossword: Glomerulonephritis
A man with a hole in his penis
Oxidant stress in hemodialysis: Prevention and treatment strategies
The treatment of acute interstitial nephritis: More data at last
Cardio-Kidney-Damage: a unifying concept
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Current status of maintenance hemodialysis in Beijing, China
Volume 63, Issue 2, Pages (February 2003)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Volume 75, Issue 7, Pages (April 2009)
The International Pediatric Peritonitis Registry: Starting to walk
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
Where vaptans do and do not fit in the treatment of hyponatremia
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Laura M. Krinsky, William J. Levine  Kidney International 
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Volume 68, Issue 4, Pages (October 2005)
Atrial fibrillation in incident dialysis patients
Presentation transcript:

Is hemodiafiltration the technical solution to chronic inflammation affecting hemodialysis patients?  Antonio Santoro, Elena Mancini  Kidney International  Volume 86, Issue 2, Pages 235-237 (August 2014) DOI: 10.1038/ki.2014.81 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Elements for the realization of a low-inflammatory-impact dialysis treatment. Because of the multifactorial nature of inflammation in the chronic hemodialysis patient, an approach on several fronts should be implemented: on the one hand, the elimination of the factors inducing an inflammatory response, and on the other, the direct removal of the inflammatory mediators. Among the former, a high-quality water treatment system, the exclusive use of ultrapure dialysis fluids, and the avoidance of acetate in dialysate, as well as the use of highly biocompatible materials, are the main steps. Among the latter, apart from the mandatory use of high-flux membranes, adsorptive membrane, as well as the direct adsorption of inflammatory mediators on the sorbent cartridge, to arrive at the high-volume convection associated or not to diffusion are the different possible options. Kidney International 2014 86, 235-237DOI: (10.1038/ki.2014.81) Copyright © 2014 International Society of Nephrology Terms and Conditions